Stock TOVX THERIVA BIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Theriva Biologics, Inc.

Equities

TOVX

US87164U4094

Delayed Nyse
Other stock markets
 12:50:47 2024-06-10 pm EDT 		5-day change 1st Jan Change
0.2473 USD -6.22% Intraday chart for Theriva Biologics, Inc. -5.97% -42.50%
May. 23 Theriva Biologics Gets Fast Track Designation for Pancreatic Cancer Treatment MT
May. 23 Theriva Biologics, Inc Announces U.S. Food and Drug Administration Granted Fast Track Designation CI

Evolution of the average Target Price on Theriva Biologics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

4bdff657b8f5.i2St_fBaDUG7nxikD2QV4caNqnJIyEbZKTMgeEQXUo4.7ijBhLIbYDOK7E7xPQAnmInF-RoBlzW6RXZ5NjJ8Ee26IPSngGtiJvT4SQ~298b5407cd774d84f4082dcf61f46dc9

Analyst Recommendations on Theriva Biologics, Inc.

Cantor Fitzgerald Initiates Coverage on Synthetic Biologics With Overweight Rating MT
History shows stocks can weather rate hike cycle RE
SYNTHETIC BIOLOGICS : Maxim Upgrades Synthetic Biologics to Buy From Hold; Price Target is $2.50 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.2637 USD
Average target price
2 USD
Spread / Average Target
+658.44%
High Price Target
2 USD
Spread / Highest target
+658.44%
Low Price Target
2 USD
Spread / Lowest Target
+658.44%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Theriva Biologics, Inc.

Cantor Fitzgerald
Maxim

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. TOVX Stock
  4. Consensus Theriva Biologics, Inc.